Berenberg upgraded Givaudan (GVDNY) to Buy from Hold with a price target of CHF 4,700, up from CHF 3,850. The firm surveyed 100 experts across manufacturers and retailers to understand innovation rates in 2024 and the outlook for 2025. The survey suggests innovation launches will accelerate in 2025, with increasing promotional activity supporting end-market volume growth, the analyst tells investors in a research note. Berenberg believes this backdrop is most positive for the beauty, personal care, and ready-to-drink beverages categories. With 50% exposure to these categories, Givaudan is the best positioned of the stocks to benefit from this growth in 2025, it contends.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GVDNY:
- Givaudan SA Reports Strong 2024 Earnings Performance
- Givaudan price target lowered to CHF 4,550 from CHF 4,650 at Citi
- Givaudan price target lowered to CHF 3,850 from CHF 4,100 at Berenberg
- Givaudan price target raised to CHF 3,800 from CHF 3,750 at Barclays
- Givaudan upgraded to Overweight from Neutral at JPMorgan